Resolution of the Council of Experts "Regulatory guidelines and issues relating to the organization of screening and prediction of preeclampsia in the Russian Federation"


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

About the authors

- -

References

  1. Brown M.A., Magee L.A., Kenny L.C., Karumanchi S.A., McCarthy F.P., Saito S., Hall D.R., Warren C.E., Adoyi G., Ishaku S.; International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertensive Disorders of Pregnancy: ISSHP Classification, Diagnosis, and Management Recommendations for International Practice. Hypertension. 2018; 72(1): 24-43. https://dx.doi.org/10.1161/HYPERTENSIONAHA.117.10803.
  2. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet. 2019; 145(Suppl 1): 1-33. https://dx.doi.org/10.1002/ijgo.12802.
  3. Основные показатели деятельности службы охраны здоровья матери и ребенка в Российской Федерации. 2018.
  4. Turbeville H.R., Sasser J.M. Preeclampsia beyond pregnancy: long-term consequences for mother and child. Am J Physiol Renal Physiol. 2020; 318(6): F1315-F1326. https://dx.doi.org/10.1152/ajprenal.00071.2020.
  5. Wu P., Haththotuwa R., Kwok C.S., Babu A., Kotronias R.A., Rushton C., Zaman A., Fryer A.A., Kadam U., Chew-Graham C.A., Mamas M.A. Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis. Circ Cardiovasc Qual Outcomes. 2017; 10(2): e003497. https://dx.doi.org/10.1161/CIRCOUTCOMES.116.003497.
  6. Ходжаева З.С., Холин А.М., Вихляева Е.М. Ранняя и поздняя преэклампсия: парадигмы патобиологии и клиническая практика. Акушерство и гинекология. 2013; 10: 4-11.
  7. Khodzhaeva Z.S., Kogan Ye.A., Shmakov R.G., Klimenchenko N.I., Akatyeva A.S., Vavina O.V., Kholin A.M., Muminova K.T., Sukhikh G.T. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. J Matern Fetal Neonatal Med. 2016; 29(18): 2980-6. https://dx.doi.org/10.3109/ 14767058.2015.1111332.
  8. Lisonkova S., Joseph K.S. Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol. 2013; 209(6): 544.e1-544.e12. https://dx.doi.org/10.1016/j.ajog.2013.08.019.
  9. Ташкина Е. А., Черных Е.Р., Пасман Н.М. Роль ангиогенных факторов и их взаимодействия с иммунной системой при неосложненной беременности и преэклампсии. Национальный конгресс «Дискуссионные вопросы современного акушерства» 15-17 июня 2017 г. Журнал акушерства и женских болезней. 2017: 79.
  10. Uzan J., Carbonnel M, Piconne O., Asmar R. Pre-eclampsia: Pathophysiology, diagnosis, and management. Vasc Health Risk Manag. 2011; 7(1): 467-74. https://dx.doi.org/10.2147/VHRM.S20181.
  11. Akolekar R., Syngelaki A., Poon L., Wright D., Nicolaides K.H. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther. 2013; 33(1): 8-15. doi: 10.1159/000341264.
  12. Ходжаева З.С., Холин А.М., Шувалова М.П., Иванец Т.Ю., Демура С.А., Таличкина И.В. Российская модель оценки эффективности теста на преэклампсию sFlt-1/PlGF. Акушерство и гинекология. 2019; 2: 52-8.
  13. Kenny L.C., Black M.A., Poston L., Taylor R., Myers J.E., Baker P.N., et al. Early pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers: the Screening for Pregnancy Endpoints (SCOPE) international cohort study. Hypertens. 2014; 64(3): 644-52. https://dx.doi. org/10.1161/HYPERTENSIONAHA.
  14. O’Gorman N., Wright D., Syngelaki A., Akolekar R., Wright A., Poon L.C., et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation. Am J Obstet Gynecol. 2016; 214(1): 103. e1-103.e12. https://dx.doi.org/10.1016/j.ajog.2015.08.034.
  15. O’Gorman N., Wright D., Poon L.C., Rolnik D.L., Syngelaki A., Wright A., et al. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation. Ultrasound Obstet Gynecol. 2017; 49(6): 751-5. https://dx.doi.org/10.1002/uog.17399.
  16. Zhong Y., Zhu F., Ding Y. Serum screening in first trimester to predict preeclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth. 2015; 15:191. https://dx.doi. org/10.1186/s12884-015-0608-y.
  17. Zeisler H., Llurba E., Chantraine F., Vatish M., Staff A.C., Sennstrom M. et al. Predictive Value of the sFlt-1: PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med. 2016; 374(1): 13-22. https://dx.doi.org/10.1056/ NEJMoa1414838.
  18. Hadker N., Garg S., Costanzo C., van der Helm W., Creeden J. Are there financial savings associated with supplementing current diagnostic practice for preeclampsia with a novel test? Learnings from a modeling analysis from a German payer perspective/ Hypertens Pregnancy, 2013; 32(2): 105-19. http:// dx.doi.org/10.3109/10641955.2011.638958.
  19. Nielsen L.H., Sundtoft I., Vestgaard M.J., Persson L., Storgaard L., Salvig J.D. et al. Hypertension og preklampsi. Indholdsfortegnelse. 2018.
  20. Rana S., Powe C.E., Salahuddin S., Verlohren S., Perschel F.H., Levine R.J., et al. Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia. Circulation. 2012; 125(7): 911-9. https://dx.doi. org/10.1161/CIRCULATIONAHA.111.054361.
  21. Poon L.C., Galindo A., Surbek D., Chantraine F., Stepan H., Hyett J., Tan K.H., Verlohren S. From first-trimester screening to risk stratification of evolving preeclampsia in the second and third trimesters of pregnancy: a comprehensive approach. Ultrasound Obstet Gynecol. 2020; 55(1): 5-12. https://dx.doi. org/10.1002/uog.21869.
  22. Stepan H., Hund M., Dilba P., Sillman J., Schlembach D. Elecsys® and Kryptor immunoassays for the measurement of sFlt-1 and PlGF to aid preeclampsia diagnosis: are they comparable? Clin Chem Lab Med. 2019; 57(9): 1339-48. http://dx.doi.org/10.1515/cclm-2018-1228.
  23. Perdigao J.L, Chinthala S., Mueller A., Minhas R., Ramadan H., Nasim R. et al. Angiogenic Factor Estimation as a Warning Sign of Preeclampsia-Related Peripartum Morbidity Among Hospitalized Patients. Hypertension. 2019; 73(4): 868-77. https://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12205.
  24. Droge L.A., Holler A., Ehrlich L., Verlohren S., Henrich W., Perschel F.H. Diagnosis of preeclampsia and fetal growth restriction with the sFlt-1/PlGF ratio: Diagnostic accuracy of the automated immunoassay Kryptor®. Pregnancy Hypertens. 2017; 8: 31-6. https://dx.doi.org/10.1016/j.preghy.2017.02.005.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies